North America is expected to dominate Laboratory Equipment Services Market in 2016

North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Asia is expected to grow at the highest CAGR during the forecast period, due to the rising focus of pharmaceutical and biotechnology industries on developing Asian countries.

The report “Laboratory Equipment Services Market by Service (Repair, Calibration, Validation), Equipment (Analytical, Specialty), Service Provider (OEM, Third Party), Service Contracts (Standardized, and Customized), End User – Global Forecast to 2021″, The global laboratory equipment services market, in terms of value, is projected to reach USD 11.51 Billion by 2021 from USD 6.50 Billion in 2016, at a CAGR of 10.0% during the forecast period.

Growth in this market is mainly driven by increasing research in pharmaceutical and biotechnology industries and the growing need for timely and effective diagnosis of diseases. Furthermore, developing markets such as India and China and the increasing number of asset management companies provide significant growth opportunities for the laboratory equipment services market. On the other hand, factors such as increasing focus among healthcare providers to reduce the cost of treatments, growing pressure on pharmaceutical companies to reduce the costs of marketing their drugs, and high cost of contracts for servicing laboratory equipment may restraint the growth of the market.

The laboratory equipment services market is segmented based on service type, equipment type, service contract, service provider, end user, and regions.

Based on service type, the market is segmented into repair and maintenance, calibration, validation, and other services. The repair and maintenance services segment is expected to account for the largest market share in 2016. They key factor driving the growth of this segment is the rising use of laboratory equipment

Based on region, the laboratory equipment services market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is further subsegmented into Japan, China, India, and Rest of Asia (RoA). In 2016, North America is expected to dominate the market, followed by Asia. The increase in the number of clinical trials will help this market to witness significant growth, by driving the purchase and use of advanced equipment. Apart from this, increased spending by laboratories on equipment purchasing will help the market grow by expanding the end-user base for associated services. Asia is poised to be the fastest-growing region in this market, mainly due to the increasing focus of the pharmaceutical and biotechnology industries on developing Asian countries for conducting clinical trials. This is because Asian markets offer a significant cost advantage and have a skilled workforce.